Victory Capital Management’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-13,294
Closed -$55.8K 2663
2023
Q1
$55.8K Sell
13,294
-243
-2% -$1.26K ﹤0.01% 2433
2022
Q4
$81.4K Buy
13,537
+1,849
+16% +$10.1K ﹤0.01% 2390
2022
Q3
$68K Sell
11,688
-2,549
-18% -$15.9K ﹤0.01% 2528
2022
Q2
$85K Buy
14,237
+1,518
+12% +$7.77K ﹤0.01% 2482
2022
Q1
$65K Sell
12,719
-363
-3% -$1.08K ﹤0.01% 2572
2021
Q4
$32K Buy
13,082
+205
+2% +$502 ﹤0.01% 2664
2021
Q3
$38K Sell
12,877
-646
-5% -$1.76K ﹤0.01% 2704
2021
Q2
$34K Buy
13,523
+2,366
+21% +$5.67K ﹤0.01% 2685
2021
Q1
$32K Buy
11,157
+37
+0.3% +$121 ﹤0.01% 2700
2020
Q4
$36K Buy
11,120
+573
+5% +$1.91K ﹤0.01% 2477
2020
Q3
$23K Sell
10,547
-603
-5% -$770 ﹤0.01% 2432
2020
Q2
$13K Sell
11,150
-12,942
-54% -$13.7K ﹤0.01% 2463
2020
Q1
$22K Buy
+24,092
New +$27.6K ﹤0.01% 3081
2019
Q4
Sell
-9,800
Closed -$8K 3790
2019
Q3
$8K Buy
+9,800
New +$7.48K ﹤0.01% 3359

Other funds holding CTIC